Free Trial

Capricor Therapeutics (CAPR) Short Interest Ratio & Short Volume

Capricor Therapeutics logo
$18.92 +0.46 (+2.49%)
(As of 11/20/2024 ET)

Capricor Therapeutics Short Interest Data

Capricor Therapeutics (CAPR) has a short interest of 5.28 million shares. This marks a -14.56% decrease in short interest from the previous month. The short interest ratio (days to cover) is 1.8, indicating that it would take 1.8 days of the average trading volume of 1.15 million shares to cover all short positions.

Current Short Interest
5,280,000 shares
Previous Short Interest
6,180,000 shares
Change Vs. Previous Month
-14.56%
Dollar Volume Sold Short
$106.13 million
Short Interest Ratio
1.8 Days to Cover
Last Record Date
October 31, 2024
Outstanding Shares
45,470,000 shares
Percentage of Shares Shorted
11.61%
Today's Trading Volume
818,151 shares
Average Trading Volume
1,153,967 shares
Today's Volume Vs. Average
71%
Short Selling Capricor Therapeutics?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Capricor Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

CAPR Short Interest Over Time

CAPR Days to Cover Over Time

CAPR Percentage of Float Shorted Over Time

Capricor Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
10/31/20245,280,000 shares $106.13 million -14.6%N/A1.8 $20.10
10/15/20246,180,000 shares $133.49 million +17.9%N/A2.1 $21.60
9/30/20245,240,000 shares $79.70 million -30.4%N/A2.1 $15.21
9/15/20247,530,000 shares $34.56 million +0.8%N/A8.5 $4.59
8/31/20247,470,000 shares $34.14 million +6.7%N/A19.5 $4.57
8/15/20247,000,000 shares $27.30 million +12.7%N/A16.5 $3.90
7/31/20246,210,000 shares $25.21 million +5.8%N/A14.4 $4.06
7/15/20245,870,000 shares $27.35 million +25.7%N/A13.6 $4.66
6/30/20244,670,000 shares $22.28 million +3.6%N/A10.8 $4.77
6/15/20244,510,000 shares $23.32 million -1.3%N/A12.6 $5.17
5/31/20244,570,000 shares $25.96 million +8.6%N/A12 $5.68
5/15/20244,210,000 shares $22.44 million +1.7%N/A11.6 $5.33
4/30/20244,140,000 shares $21.82 million +15.3%N/A12.8 $5.27
4/15/20243,590,000 shares $21.04 million +2.6%N/A12 $5.86
3/31/20243,500,000 shares $23.77 million +8.4%N/A13 $6.79
3/15/20243,230,000 shares $20.64 million +19.6%N/A11.8 $6.39
2/29/20242,700,000 shares $11.34 million +0.8%N/A10.3 $4.20
2/15/20242,680,000 shares $10.10 million -0.4%N/A11.5 $3.77
1/31/20242,690,000 shares $10.87 million No ChangeN/A11.2 $4.04
1/15/20242,690,000 shares $11.89 million +14.5%N/A11 $4.42
12/31/20232,350,000 shares $11.49 million +10.3%N/A9.6 $4.89
12/15/20232,130,000 shares $9.24 million +45.9%N/A7.2 $4.34
11/30/20231,460,000 shares $4.34 million +7.4%N/A5.8 $2.97
11/15/20231,360,000 shares $4.37 million +10.6%N/A5.4 $3.21
10/31/20231,230,000 shares $3.47 million +1.7%N/A4.7 $2.82
10/15/20231,210,000 shares $3.46 million +80.8%N/A5 $2.86
9/30/2023669,100 shares $2.29 million +22.2%N/A3.2 $3.42
9/15/2023547,600 shares $3.43 million +36.4%N/A4.4 $6.26
8/31/2023401,500 shares $2.60 million +27.3%N/A3.2 $6.48
8/15/2023315,500 shares $2.25 million +14.0%N/A3.1 $7.14
7/31/2023276,700 shares $1.22 million +0.8%N/A3.7 $4.40
7/15/2023274,500 shares $1.23 million -0.3%N/A4 $4.48
6/30/2023275,200 shares $1.32 million +6.5%N/A3.7 $4.78
6/15/2023258,400 shares $1.24 million +0.8%N/A3.5 $4.80
5/31/2023256,300 shares $1.16 million -13.1%N/A3.8 $4.53
5/15/2023294,800 shares $1.24 million +11.0%N/A4.1 $4.19
4/30/2023265,700 shares $1.03 million +0.5%N/A3.5 $3.89
4/15/2023264,500 shares $1.16 million -3.8%N/A2.9 $4.38
3/31/2023274,800 shares $1.16 million -22.3%N/A2.9 $4.22
3/15/2023353,500 shares $1.58 million +4.5%N/A3.5 $4.47
When it comes to NVDA… “acceleration cycles” are the key (Ad)

Expert options trader Graham Lindman has been working on a new way to tap into Nvidia’s options… By simply isolating outsized “acceleration cycles” within Nvidia stock (most investors don’t even know it exists)... And thanks to many months and late nights working out the kinks of the systems… They have finally found a way to target these cycles on Nvidia over and over again.

Use this link to see Nvidia Unchained right away!
2/28/2023338,200 shares $1.54 million +8.7%N/A3.3 $4.55
2/15/2023311,100 shares $1.25 million -5.2%N/A2.9 $4.03
1/31/2023328,300 shares $1.39 million -4.3%N/A2.8 $4.22
1/15/2023343,100 shares $1.50 million +0.7%N/A2.8 $4.38
12/30/2022340,900 shares $1.32 million +9.4%N/A2.5 $3.86
12/15/2022311,700 shares $1.21 million +30.8%N/A1.9 $3.89
11/30/2022238,400 shares $1.07 million -8.5%N/A1.4 $4.47
11/15/2022260,600 shares $1.06 million +5.3%N/A1.4 $4.09
10/31/2022247,500 shares $1.38 million -16.9%N/A1.2 $5.56
10/15/2022297,800 shares $1.74 million -10.0%N/A1.5 $5.83
9/30/2022330,900 shares $1.99 million +55.3%N/A1.7 $6.00
9/15/2022213,100 shares $1.25 million -25.5%N/A1.2 $5.87
8/31/2022286,100 shares $1.67 million -5.9%N/A1.7 $5.82
8/15/2022304,100 shares $1.49 million -15.2%N/A2.2 $4.89
7/31/2022358,500 shares $1.65 million -9.1%N/A3.2 $4.61
7/15/2022394,500 shares $1.99 million -9.6%N/A3.4 $5.05
6/30/2022436,600 shares $1.52 million -12.5%N/A3.8 $3.49
6/15/2022499,100 shares $2.05 million -2.7%2.5%3.1 $4.11
5/31/2022512,800 shares $1.86 million -8.6%N/A3 $3.63
5/15/2022561,000 shares $1.72 million -4.4%N/A3 $3.06
4/30/2022586,600 shares $1.86 million -9.2%N/A2.9 $3.17
4/15/2022645,800 shares $2.12 million -7.1%N/A1.7 $3.29
3/31/2022695,100 shares $2.38 million -3.2%N/A1.8 $3.43
3/15/2022718,300 shares $2.97 million -20.7%N/A2.1 $4.14
2/28/2022905,200 shares $3.67 million +4.1%N/A2.6 $4.05
2/15/2022869,900 shares $3.76 million -7.0%N/A2.5 $4.32
1/31/2022934,900 shares $3.34 million +69.6%N/A2.6 $3.57
1/15/2022551,200 shares $1.70 million -18.3%N/A1.9 $3.09
12/31/2021675,000 shares $1.98 million -13.7%N/A3.5 $2.93
12/15/2021781,900 shares $2.47 million -12.1%N/A1.2 $3.16
11/30/2021889,000 shares $3.00 million -2.5%N/A1.3 $3.37
11/15/2021912,000 shares $3.12 million +0.4%N/A1.4 $3.42
10/29/2021908,600 shares $3.38 million -11.8%4.0%1.4 $3.72
10/15/20211,030,000 shares $4.08 million -12.0%4.6%1.6 $3.96
9/30/20211,170,000 shares $4.70 million +60.5%5.2%1.7 $4.02
9/15/2021728,900 shares $3.24 million +8.6%3.2%1.1 $4.45
8/31/2021671,100 shares $3.36 million -10.3%3.0%1.9 $5.01
8/13/2021748,100 shares $3.02 million -30.7%3.3%2.2 $4.04
7/30/20211,080,000 shares $4.72 million -49.8%4.8%3 $4.37
7/15/20212,150,000 shares $9.31 million -4.9%9.6%3.9 $4.33
6/30/20212,260,000 shares $11.59 million +17.7%10.1%4.1 $5.13
6/15/20211,920,000 shares $8.70 million +10.3%8.6%3.6 $4.53
5/28/20211,740,000 shares $6.59 million -0.6%7.8%4.1 $3.79
5/14/20211,750,000 shares $5.53 million +53.5%N/A3.7 $3.16
4/30/20211,140,000 shares $5.18 million +30.7%N/A2.1 $4.54
4/15/2021872,200 shares $3.55 million -7.2%N/A1.4 $4.07
3/31/2021939,500 shares $4.34 million +116.8%N/A1 $4.62
3/15/2021433,400 shares $2.25 million +25.6%N/A0.4 $5.18
2/26/2021345,200 shares $2.12 million -29.4%N/A0.4 $6.14
2/12/2021489,100 shares $3.81 million -29.3%N/A0.5 $7.80
When it comes to NVDA… “acceleration cycles” are the key (Ad)

Expert options trader Graham Lindman has been working on a new way to tap into Nvidia’s options… By simply isolating outsized “acceleration cycles” within Nvidia stock (most investors don’t even know it exists)... And thanks to many months and late nights working out the kinks of the systems… They have finally found a way to target these cycles on Nvidia over and over again.

Use this link to see Nvidia Unchained right away!
1/29/2021691,900 shares $4.41 million -9.5%N/A0.7 $6.38
1/15/2021764,800 shares $3.70 million +0.9%N/A0.9 $4.84
12/31/2020758,000 shares $2.80 million -0.9%N/A1.2 $3.70
12/15/2020765,000 shares $3.27 million -29.8%N/A1.6 $4.27
11/30/20201,090,000 shares $4.68 million -12.1%N/A1.5 $4.29
11/15/20201,240,000 shares $5.39 million +4.2%N/A1.4 $4.35
10/30/20201,190,000 shares $4.95 million -9.9%N/A1.2 $4.16
10/15/20201,320,000 shares $6.40 million -8.3%N/A0.6 $4.85
9/30/20201,440,000 shares $7.56 million -1.4%N/A0.5 $5.25
9/15/20201,460,000 shares $6.83 million -24.0%N/A0.5 $4.68
8/31/20201,920,000 shares $11.58 million -6.8%N/A0.7 $6.03
8/14/20202,060,000 shares $12.75 million +73.1%N/A0.8 $6.19
7/31/20201,190,000 shares $9.47 million +166.9%N/A0.4 $7.96
7/15/2020445,900 shares $1.82 million +0.7%N/A0.1 $4.08
6/30/2020442,700 shares $2.09 million +61.5%N/A0.1 $4.73
6/15/2020274,200 shares $1.29 million +136.4%N/A0 $4.70
5/29/2020116,000 shares $538,240.00 -87.1%N/A0 $4.64
5/15/2020897,400 shares $5.38 million +187.7%N/A0.2 $5.99
4/30/2020311,900 shares $2.18 million +322.1%N/A0.1 $7.00
4/15/202073,900 shares $110,850.00 +8.7%N/A0.1 $1.50
3/31/202068,000 shares $169,320.00 +161.5%N/A0.1 $2.49
3/13/202026,000 shares $42,380.00 -10.7%N/A0.1 $1.63
2/28/202029,100 shares $33,756.00 +140.5%N/A0.1 $1.16
2/14/202012,100 shares $11,374.00 +80.6%0.4%0.1 $0.94
1/31/20206,700 shares $8,107.00 -86.1%0.2%0 $1.21
1/15/202048,100 shares $65,416.00 +75.6%1.5%0.3 $1.36
12/31/201927,400 shares $48,498.00 -90.8%0.9%0.2 $1.77

CAPR Short Interest - Frequently Asked Questions

What is Capricor Therapeutics' current short interest?

Short interest is the volume of Capricor Therapeutics shares that have been sold short but have not yet been closed out or covered. As of October 31st, investors have sold 5,280,000 shares of CAPR short. Learn More on Capricor Therapeutics' current short interest.

What is a good short interest ratio for Capricor Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CAPR shares currently have a short interest ratio of 2.0. Learn More on Capricor Therapeutics's short interest ratio.

Which institutional investors are shorting Capricor Therapeutics?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Capricor Therapeutics: Jane Street Group LLC, Ikarian Capital LLC, and LMR Partners LLP. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Is Capricor Therapeutics' short interest increasing or decreasing?

Capricor Therapeutics saw a decrease in short interest during the month of October. As of October 31st, there was short interest totaling 5,280,000 shares, a decrease of 14.6% from the previous total of 6,180,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Capricor Therapeutics' short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Capricor Therapeutics: Clearside Biomedical, Inc. (2.32%), Leap Therapeutics, Inc. (3.54%), Tonix Pharmaceuticals Holding Corp. (5.59%), NeuroBo Pharmaceuticals, Inc. (0.64%), ProPhase Labs, Inc. (0.65%), Apellis Pharmaceuticals, Inc. (16.71%), PTC Therapeutics, Inc. (6.34%), MoonLake Immunotherapeutics (15.30%), HUTCHMED (China) Limited (0.33%), Agios Pharmaceuticals, Inc. (7.85%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks.

What does it mean to sell short Capricor Therapeutics stock?

Short selling CAPR is an investing strategy that aims to generate trading profit from Capricor Therapeutics as its price is falling. CAPR shares are trading up $0.46 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Capricor Therapeutics?

A short squeeze for Capricor Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CAPR, which in turn drives the price of the stock up even further.

How often is Capricor Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CAPR, twice per month. The most recent reporting period available is October, 31 2024.




This page (NASDAQ:CAPR) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners